couter

The Read

Flowers Foods’ stock sharply declined on concerns over its $2.
Nov 6, 2026 — Q3 2026 Earnings Release
Chart by TradingView

The schedule

  • Fri6Nov

    Q3 results will provide an update on margin resilience against persistent packaged food input inflation and consumer trade-down pressures.

  • Tue9Feb

    Full-year results and 2027 guidance, which historically serves as a major catalyst for structural repricing.

  • Wed24Mar

    Broad consumer staples re-evaluation regarding the sustained volume impact of GLP-1 weight loss drugs on snacking portfolios.

  • Mon10May

    Q1 earnings print with emphasis on YoY comparisons post-dividend cut and traction of the Simple Mills acquisition.

  • Thu29Jul

Past

  • Tue6Oct

    Market scrutiny on the $2.04B debt load and potential non-core brand sales to stabilize the balance sheet.

  • Thu13Aug

    Actual outcome: Bear

    Flowers Foods reported in-line Q2 EPS of $0.20, but the stock fell below the bear floor to close at $7.38. The bearish price action was driven by anticipated sales declines amid consumer pressure and loaf softness, alongside reports that the company is seeking to divest its Tastykake business. Furthermore, market warnings regarding the sustainability of its high dividend yield weighed heavily on investor sentiment.

    Q2 earnings focus shifts to debt paydown trajectory and margin expansion following the strategic 50% dividend cut.

  • Thu21May

    Actual outcome: Bull · $7.79 at outcome

    Flowers Foods delivered a Q1 earnings beat, reporting $0.29 per share against estimates of $0.28, alongside a 1.1% rise in sales aided by pricing gains and the Simple Mills acquisition. The stock rallied 11.1% as investors reacted positively to the company's strategic 50% dividend cut, which freed up essential capital to address its heavy debt load and demonstrated a clear commitment to balance sheet improvement despite broader volume pressures.

  • Mon30Mar

    Actual outcome: Mixed · $8.24 at outcome

    Flowers Foods faced a wave of negative developments, including the departure of its Chief Growth Officer, a Deutsche Bank downgrade lowering the price target to $7.00, and significant insider selling by the CEO. Despite these bearish signals and the stock touching a new 52-week low, the overall price decline was relatively muted at just 1.6% by the outcome date, resulting in a mixed classification.

  • Wed25Feb

    Actual outcome: Bear · $9.66 at outcome

    Although Flowers Foods beat Q4 earnings estimates with an EPS of $0.22, the stock plummeted due to weak 2026 guidance that cited persistent inflationary pressures and softening consumer demand. Investor confidence was further shaken by reports that the company might sell off brands to sustain its dividend, alongside broader market concerns regarding the impact of GLP-1 drugs on the packaged food category, driving the price well below the bear floor.

  • Tue17Feb

    Actual outcome: Bear · $8.66 at outcome

    Despite a Q4 earnings beat, the stock fell well below the bear floor as the market focused on soft 2026 guidance and persistent concerns regarding the company's $2.1B debt load. Analyst downgrades to 'Reduce' and a Zacks 'Strong Sell' rating, alongside reports that the company might need to sell brands to sustain its dividend, signaled significant financial strain to investors.